Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006913

Chief Medical Officer acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kropotova Alexandra Chief Medical Officer 2023-03-14 Grant or award +275,000 275,000 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…